CEO of Pfizer partner Biontech says coming winter will be 'hard,' but by April, 300 million immunization units should be ready, which will have an impact on global pandemic
Country is poised to clinch millions of Pfizer vials, but the devil's in the details: The shots require unique, unprecedented storage and transport conditions. Will we be ready?
PM says Israel will receive enough doses to inoculate 4 million Israelis, though reports say deal allows company to pull out of its promises if circumstances demand
Uğur Şahin of BioNTech, which created shot with the US pharmaceutical company, tells The Guardian that the virus 'can't defend itself' against prospective vaccine
Daily warns readers Albert Bourla, a Greek Jew, will 'stick the needle' in them, calls prospective COVID vaccine 'poison'; its publisher was convicted of anti-Semitic defamation
PM says all legal impediments to deal removed, he's also working on securing immunizations from other sources; outgoing virus czar predicts vaccines won't arrive before March
Prime minister holds second round of talks with pharma firm's CEO, but health minister warns actual delivery of any doses will take months in best-case scenario
US biotech giant, which has a contract with Israel to supply coronavirus shots when developed, could apply for emergency FDA approval in early December
Public broadcaster says acquisition talks with US pharma firm being led by junior officials, prompting criticism of Health Ministry director for not prioritizing the purchase
Recent comments